SK Capital/Lisi Medical
Transaction details
The proposed acquisition by Remmele Acquisition and Girard Acquisition SAS which are each controlled by Precision Holdings, LP, which is indirectly majority owned and solely controlled by funds that are controlled by affiliates of SK Capital Partners L.P. of sole control of Lisi Medical Remmele LLC, Lisi Medical SAS and their subsidiaries has been cleared by the Competition and Consumer Protection Commission.
Case details
- Notification date:27 July 2025
- Publication date:27 July 2025
- Economic sector:Manufacturing - C
- Economic sub-sector:Other manufacturing - C.32
- Simplified merger:Yes
- Outcome:Cleared
Documents
M.25.044 Merger AnnouncementPDF | 111 KBM.25.044 Merger Announcement PDF | 111 KB - Opens in new window
M.25.044 DeterminationPDF | 260 KBM.25.044 Determination PDF | 260 KB - Opens in new window
Timetable
Parties Involved
SK Capital
SK Capital Partners is a US-based private investment firm focused on the specialty materials, chemicals and pharmaceutical sectors. It was founded in 2007 and is based in New York, USA. SK Capital Partners is active globally, through its portfolio companies, with a specific focus on North America, the EEA, the Middle East and Australia.
Lisi Medical
The Lisi Medical group comprises 4 entities, of which 3 are incorporated in France and one in the United States of America. The Lisi Medical group is active as a contract manufacturing organisation in the MedTech field, specialising in the industrial manufacturing of implants and instruments for minimally invasive, orthopaedic, spinal and trauma surgery. The Lisi Medical group provides its products to original equipment manufacturers of medical and surgical devices who sell the finished products under their branding to end customers.
Contacts
Eadaoin Burnseadaoinburns@ccpc.ie Iseult O'Kelly iseultokelly@ccpc.ie
